DUAVIVE 0.45 mg / 20 mg modified-release tablets

Licence status
Authorised: 16/12/2014
Active substances
Conjugated estrogens (ce), Bazedoxifene acetate
Dosage Form
Modified-release tablet
Licence number
EU/1/14/960/001
Licence holder
Pfizer Europe MA EEIG

Product documents

Licence information

ATC code
G03CX Other estrogens
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
16/12/2014